Skip to main content
Fig. 3 | BMC Health Services Research

Fig. 3

From: Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza

Fig. 3

How often do you prescribe neuraminidase inhibitors empirically (i.e. before any influenza test result becomes available) in the following groups of adults hospitalised during the influenza season?

Legend: PNA – pneumonia, CLD - Exacerbation of chronic lung disease (e.g. COPD, asthma), LRTI – non-pneumonic lower respiratory tract infection, Other – other acute medical illnesses e.g. cardiac failure

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us